Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials
Launched by FRED HUTCHINSON CANCER CENTER · Jul 1, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding ways to help more patients participate in cancer clinical trials, which are important for developing new treatments and improving care. The study is looking at a program called GUIDE, which uses a trained navigator to assist patients who might face challenges in joining a clinical trial. These challenges could include things like financial difficulties, lack of transportation, or concerns about insurance and costs. By providing support and guidance, the trial aims to increase both participation and diversity among patients with breast, digestive, and genitourinary cancers.
To be eligible for this trial, participants need to be at least 18 years old and identified as potentially eligible for an open clinical trial related to breast, digestive, or genitourinary cancers. They should also have at least one health-related social need, such as issues with food, housing, transportation, or financial stability. Participants will receive assistance from a navigator who will help them address these barriers to joining a trial. This is an opportunity for patients to engage in research that could lead to better treatments while receiving support tailored to their needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 18 years of age
- • Identified as potentially eligible for an open clinical trial by clinical trial pre-screening (operating in breast, gastrointestinal \[GI\], and genitourinary \[GU\] clinics)
- • Have ≥ 1 health related social need, defined by
- • Food insecurity, housing instability, transportation challenges, or financial instability documented in the Supportive Cancer Care Questionnaire in Epic Electronic Medical Record (EPIC), OR
- • Concerns about insurance, cost of trial, additional trial visits, travel, transportation, childcare, OR unable to take time off work documented by clinical trial pre-screening (CTPS), OR
- • Medicaid insurance documented in EPIC
- • Able to speak English
- Exclusion Criteria:
- • Unable to speak English
- • Children, adolescents, and teens under the age of 18 years
- • Patients participating on clinical trials providing financial navigation, such as clinicaltrials.gov identifier (CT ID): NCT04960787
- • Patients refusing to sign Health Insurance Portability and Accountability Act (HIPAA) authorization
About Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center is a leading nonprofit research institution dedicated to the pursuit of innovative cancer treatments and prevention strategies. Established in Seattle, Washington, the center is renowned for its pioneering work in hematopoietic cell transplantation and its commitment to advancing cancer research through collaborative clinical trials. By integrating cutting-edge science with compassionate patient care, Fred Hutchinson Cancer Center aims to improve outcomes for patients while fostering a multidisciplinary approach to tackling complex cancer challenges. With a strong emphasis on translating research findings into clinical applications, the center is at the forefront of developing novel therapies that offer hope to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Jason Mendoza, MD, MPH
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported